Meloxicam Oral Suspension Patent Expiration

Meloxicam Oral Suspension Petitions

Details of Meloxicam Oral Suspension's suitability petitions are listed below.

Petitioner	Action	Date of Action	Description

Aurora Pharmaceutical, Inc.	Approved	27 Jan, 2023	The proposed change is for an oral solution ; the RLNAD is approved as an oral suspension .

Meloxicam Oral Suspension is a drug owned by FELIX PHARMACEUTICALS PVT. LTD. Meloxicam Oral Suspension uses Meloxicam as the active ingredient.

Meloxicam Oral Suspension uses Meloxicam as the active ingredient. Check out other Drugs and Companies using Meloxicam ingredient.